Dormabrol

Dormabrol Brand names, Dormabrol Analogs

Dormabrol Brand Names Mixture

No information avaliable

Dormabrol Chemical_Formula

C₂₀H₂₃NS

Dormabrol RX_link

No information avaliable

Dormabrol fda sheet

Dormabrol msds (material safety sheet)

Dormabrol Synthesis Reference

No information avaliable

Dormabrol Molecular Weight

309.469 g/mol

Dormabrol Melting Point

< 25 ^oC

Dormabrol H₂O Solubility

Soluble as HCl salt

Dormabrol State

Liquid

Dormabrol LogP

5.7

Dormabrol Dosage Forms

Tablets (oral, 1 mg)

Dormabrol Indication

Used for the symptomatic treatment of parkinsonism.

Dormabrol Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Dormabrol Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Dormabrol side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Dormabrol Patient Information

Dormabrol Organisms Affected

Humans and other mammals